A new study evaluating the safety of POMELLA® Extract has been accepted in peer review by the journal Food and Chemical Toxicology.
The study concluded that the no-observed-adverse-effect level (NOAEL) of POMELLA® Extract is 600 mg/kg/day—the highest dose tested—which is exponentially higher than the recommended daily dosage of POMELLA. The study tested several doses of the clinically researched, punicalagins-standardized pomegranate extract over a 90-day period.
“As one of the first systematic safety studies performed on a commercial pomegranate extract, this study breaks new ground in our long-term commitment to ensure the safety and efficacy of our products,” said Blake Ebersole, Technical Director of Verdure Sciences.
POMELLA® Extract is the patent-pending, all-natural pomegranate extract manufactured under cGMP, ISO-9000:2001, HACCP standards; is Kosher- and Halal-certified and GMO-free; and now available in USDA Certified Organic forms.
More information can be found at www.pomextract.com
About Verdure Sciences
Verdure Sciences strives to offer the most innovative bionutritionals through the integration of proprietary offerings, expertise and consummate resources.
With the main focus on research and production capabilities, an extensive pipeline of clinically studied products is geared to the needs of general populations and subpopulations with special health concerns.
Reference: Food Chem Toxicol. 2008 Aug;46(8):2728-35